Nabors Energy Transition Corp. II 10-Q 25 Aug 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Jun. 30, 2023	Aug. 25, 2023
Document and entity information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-41744
Entity Registrant Name	NABORS ENERGY TRANSITION CORP. II
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1729137
Entity Address, Address Line One	515 West Greens Road
Entity Address, Adress Line Two	Suite 1200
Entity Address, City or Town	Houston
Entity Address State Or Province	TX
Entity Address, Postal Zip Code	77067
City Area Code	281
Local Phone Number	874-0035
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Central Index Key	0001975218
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false
Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one warrant
Document and entity information
Title of 12(b) Security	Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-half of one warrant
Trading Symbol	NETDU
Security Exchange Name	NASDAQ
Class A ordinary shares
Document and entity information
Title of 12(b) Security	Class A ordinary shares, par value $0.0001 per share
Trading Symbol	NETD
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		30,500,000
Warrants, exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Document and entity information
Title of 12(b) Security	Warrants, exercisable for one Class A ordinary share at an exercise price of $11.50 per share
Trading Symbol	NETDW
Security Exchange Name	NASDAQ
Class B ordinary shares
Document and entity information
Entity Common Stock, Shares Outstanding		0
Class F ordinary shares
Document and entity information
Entity Common Stock, Shares Outstanding		8,625,000

CONDENSED BALANCE SHEET

CONDENSED BALANCE SHEET	Jun. 30, 2023 USD ($)
Assets
Deferred offering costs	$ 1,007,333
Total assets	1,007,333
Current liabilities
Accrued offering costs	575,342
Accrued expenses	6,412
Promissory note - related party	158,006
Total current liabilities	739,760
Deferred legal fees	250,000
Total liabilities	989,760
Commitments and contingencies
Shareholder's Equity
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital	24,137
Accumulated deficit	(7,427)
Total shareholder's equity	17,573
Total Liabilities and Shareholder's Equity	1,007,333
Class A ordinary shares
Shareholder's Equity
Ordinary shares	0
Class B ordinary shares
Shareholder's Equity
Ordinary shares	0
Class F ordinary shares
Shareholder's Equity
Ordinary shares	$ 863	[1]
[1] This number includes up to 1,125,000 Class F ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period (see Note 5). The underwriters purchased 500,000 units subject to the over-allotment option on July 18, 2023 and as a result, only 1,000,000 Class F ordinary shares are subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period.

CONDENSED BALANCE SHEET (Parent

CONDENSED BALANCE SHEET (Parenthetical) - $ / shares				3 Months Ended
	Jul. 18, 2023	Jul. 17, 2023	Jul. 13, 2023	Jun. 30, 2023
Preference shares, par value				$ 0.0001
Preference shares, shares authorized				5,000,000
Preference shares, shares issued				0
Preference shares, shares outstanding				0
Over-allotment option | Subsequent Event
Period of over-allotment	45 days	45 days
Number of units sold	500,000
Class A ordinary shares
Ordinary shares, par value				$ 0.0001
Ordinary shares, shares authorized				500,000,000
Ordinary shares, shares issued				0
Ordinary shares, shares outstanding				0
Class B ordinary shares
Ordinary shares, par value				$ 0.0001
Ordinary shares, shares authorized				50,000,000
Ordinary shares, shares issued				0
Ordinary shares, shares outstanding				0
Class F ordinary shares
Ordinary shares, par value				$ 0.0001
Ordinary shares, shares authorized				50,000,000
Ordinary shares, shares issued				8,625,000
Ordinary shares, shares outstanding				8,625,000
Class F ordinary shares | Subsequent Event
Number of shares subject to forfeiture			100,000
Class F ordinary shares | Over-allotment option
Maximum number of shares subject to forfeiture				1,125,000
Period of over-allotment				45 days
Number of shares subject to forfeiture				1,125,000
Class F ordinary shares | Over-allotment option | Subsequent Event
Maximum number of shares subject to forfeiture	1,000,000
Period of over-allotment	45 days
Number of shares subject to forfeiture	1,000,000

CONDENSED STATEMENT OF OPERATIO

CONDENSED STATEMENT OF OPERATIONS	3 Months Ended
	Jun. 30, 2023 USD ($) $ / shares shares
CONDENSED STATEMENT OF OPERATIONS
Formation and operating costs | $	$ 7,427
Net loss | $	$ (7,427)
Weighted average shares outstanding of Class F ordinary shares, basic | shares	6,360,759	[1]
Weighted average shares outstanding of Class F ordinary shares, diluted | shares	6,360,759	[1],[2]
Basic net loss per ordinary share, Class F ordinary shares | $ / shares	$ 0
Diluted net loss per ordinary share, Class F ordinary shares | $ / shares	$ (0.04)
[1] This number excludes up to 1,125,000 Class F ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period (see Note 5). The underwriters purchased 500,000 units subject to the over-allotment option on July 18, 2023 and as a result, only 1,000,000 Class F ordinary shares are subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period. This number includes up to 1,125,000 Class F ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period (see Note 5). The underwriters purchased 500,000 units subject to the over-allotment option on July 18, 2023 and as a result, only 1,000,000 Class F ordinary shares are subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period.

CONDENSED STATEMENT OF OPERAT_2

CONDENSED STATEMENT OF OPERATIONS (Parenthetical) - shares				3 Months Ended
	Jul. 18, 2023	Jul. 17, 2023	Jul. 13, 2023	Jun. 30, 2023
Over-allotment option | Subsequent Event
Period of over-allotment	45 days	45 days
Number of units sold	500,000
Class F ordinary shares | Subsequent Event
Number of shares subject to forfeiture			100,000
Class F ordinary shares | Over-allotment option
Number of shares subject to forfeiture				1,125,000
Period of over-allotment				45 days
Class F ordinary shares | Over-allotment option | Subsequent Event
Number of shares subject to forfeiture	1,000,000
Period of over-allotment	45 days

CONDENSED STATEMENT OF CHANGES

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S DEFICIT - 3 months ended Jun. 30, 2023 - USD ($)		Ordinary Shares Class A ordinary shares	Ordinary Shares Class B ordinary shares	Ordinary Shares Class F ordinary shares	Additional Paid-In Capital	Accumulated Deficit	Class A ordinary shares	Class B ordinary shares	Class F ordinary shares	Total
Balance - April 12, 2023 at Apr. 11, 2023		$ 0	$ 0	$ 0	$ 0	$ 0				$ 0
Balance - April 12, 2023 (in shares) at Apr. 11, 2023		0	0	0
Issuance of Class F ordinary shares to Sponsor	[1]			$ 863	24,137					25,000
Issuance of Class F ordinary shares to Sponsor (in shares)	[1]			8,625,000
Net Income (Loss)						(7,427)				(7,427)
Balance - June 30, 2023 at Jun. 30, 2023				$ 863	$ 24,137	$ (7,427)				$ 17,573
Balance - June 30, 2023 (in shares) at Jun. 30, 2023				8,625,000			0	0	8,625,000
[1] This number includes up to 1,125,000 Class F ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period (see Note 5). The underwriters purchased 500,000 units subject to the over-allotment option on July 18, 2023 and as a result, only 1,000,000 Class F ordinary shares are subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period.

CONDENSED STATEMENT OF CHANGE_2

CONDENSED STATEMENT OF CHANGES IN SHAREHOLDER'S DEFICIT (Parenthetical) - shares				3 Months Ended
	Jul. 18, 2023	Jul. 17, 2023	Jul. 13, 2023	Jun. 30, 2023
Over-allotment option | Subsequent Event
Period of over-allotment	45 days	45 days
Number of units sold	500,000
Class F ordinary shares | Subsequent Event
Number of shares subject to forfeiture			100,000
Class F ordinary shares | Over-allotment option
Number of shares subject to forfeiture				1,125,000
Period of over-allotment				45 days
Class F ordinary shares | Over-allotment option | Subsequent Event
Number of shares subject to forfeiture	1,000,000
Period of over-allotment	45 days

CONDENSED STATEMENT OF CASH FLO

CONDENSED STATEMENT OF CASH FLOWS	3 Months Ended
	Jun. 30, 2023 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (7,427)
Adjustments to reconcile net loss to net cash used in operating activities:
Payment of formation costs through issuance of Class F ordinary shares	1,015
Changes in operating assets and liabilities:
Accrued expenses	6,412
Net cash used in operating activities	0
Net Change in Cash	0
Cash - Beginning of period	0
Cash - End of period	0
Supplemental disclosure of cash flow information:
Deferred offering costs paid through promissory note- related party	158,006
Deferred offering costs included in accrued offering costs	575,342
Deferred legal fees recorded in offering costs	250,000
Deferred offering costs paid by Sponsor in exchange for Class F ordinary shares	$ 23,985

DESCRIPTION OF ORGANIZATION AND

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	3 Months Ended
	Jun. 30, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS	NOTE 1. DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS Nabors Energy Transition Corp. II (the “Company”) was incorporated in the Cayman Islands on April 12, 2023. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities (the “Business Combination”). The Company intends to identify solutions, opportunities, companies or technologies that focus on advancing the energy transition; specifically, ones that facilitate, improve or complement the reduction of carbon or greenhouse gas emissions while satisfying growing energy consumption across markets globally. The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended (the “Securities Act”), as modified by the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). As of June 30, 2023, the Company had not yet commenced operations. All activity for the period from April 12, 2023 (inception) through June 30, 2023 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”), which is described below. The Company will not generate any operating revenues prior to the completion of the Business Combination, at the earliest, and will generate non-operating income in the form of interest income on permitted investments from the proceeds derived from the Initial Public Offering. The Company has selected December 31 as its fiscal year end. On April 24, 2023, Nabors Energy Transition Sponsor II LLC, a Cayman Islands limited liability company (the “Sponsor”), paid $25,000 to cover certain offering costs of the Company in consideration for 5,750,000 Class F ordinary shares, par value $0.0001 per share (the “Founder Shares”). On June 16, 2023, the Company issued 2,875,000 additional Founder Shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Founder Shares, for approximately $0.003 per share. The registration statement for the Company’s Initial Public Offering was declared effective on July 13, 2023. On July 18, 2023, the Company consummated the Initial Public Offering of 30,500,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “Public Shares”), which includes a partial exercise by the underwriters of their over-allotment option in the amount of 500,000 Units, at $10.00 per unit, generating gross proceeds of $305,000,000 which is discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 9,540,000 warrants (“Private Placement Warrants”) at a price of $1.00 per Private Placement Warrant, in a private placement to the direct or indirect owners of the Sponsor (the “Private Warrantholders”), generating gross proceeds of $9,540,000, which is discussed in Note 4. In addition, the direct or indirect owners of the Sponsor loaned the Company a total of $3,050,000, and in exchange, the Company issued unsecured promissory notes to each lender for an aggregate principal amount of $3,050,000 (see Note 5), as of the closing date of the Initial Public Offering at no interest, which are referred to as the Overfunding Loans. The Overfunding Loans will be repaid upon the closing of the initial Business Combination or converted into warrants of the post-business combination entity at a price of $1.00 per warrant (or any combination thereof), at the Sponsor’s discretion, which warrants will be identical to the Private Placement Warrants. The Overfunding Loans were extended in order to ensure that the amount in the Trust Account (as defined below) was $10.10 per Public Share at the closing of the Initial Public Offering. If the Company does not complete an initial Business Combination, the Company will not repay the Overfunding Loans from amounts held in the Trust Account, and the Trust Account proceeds will be distributed to the Public Shareholders (as defined below), subject to the limitations; however, the Company may repay the Overfunding Loans if there are funds available outside the Trust Account to do so. Transaction costs amounted to $17,966,142 consisting of $6,100,000 of a cash underwriting discount, $10,675,000 of deferred underwriting fees and $1,191,142 of other final offering costs. The Company’s management has broad discretion with respect to the specific application of the net proceeds of its Initial Public Offering, the sale of Private Placement Warrants and the Overfunding Loans, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. The Company’s initial Business Combination must be with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the Trust Account (net of amounts disbursed to management for working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time the Company signs a definitive agreement in connection with the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise is not required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). Following the closing of the Initial Public Offering on July 18, 2023, an amount of $308,050,000 ($10.10 per Unit) from the net proceeds of the sale of the Units in the Initial Public Offering, the sale of the Private Placement Warrants and the Overfunding Loans was placed in the trust account (“Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee and held in cash or invested in United States “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 185 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, as determined by the Company, until the earlier of: (i) the completion of a Business Combination and (ii) the distribution of the Trust Account as described below. The Company will provide holders of the Company’s outstanding Public Shares sold in the Initial Public Offering (the “Public Shareholders”) with the opportunity to redeem all or a portion of their Public Shares (including any securities for which such shares are exchanged in any prior migration or other restructuring) upon the completion of a Business Combination either (i) in connection with a general meeting called to approve the Business Combination or (ii) without a shareholder vote by means of a tender offer. Except as required by applicable law or stock exchange listing requirements, the decision as to whether the Company will seek shareholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then held in the Trust Account (initially $10.10 per Public Share). The per-share amount to be distributed to Public Shareholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 6). These Public Shares were recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if a majority of the shares voted are voted in favor of the Business Combination. If a shareholder vote is not required by law and the Company does not decide to hold a shareholder vote for business or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, shareholder approval of the transaction is required by law, or the Company decides to obtain shareholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Shareholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction. If the Company seeks shareholder approval in connection with a Business Combination, the Initial Shareholders (as defined below) have agreed to vote their Founder Shares and any Public Shares purchased during or after the Initial Public Offering in favor of a Business Combination. In addition, the Founder Shares are not entitled to redemption rights in connection with the completion of a Business Combination. Notwithstanding the foregoing, the Amended and Restated Memorandum and Articles of Association will provide that a Public Shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the Public Shares, without the prior consent of the Company. The Sponsor and the Company’s officers and directors (the “Initial Shareholders”) have agreed not to propose an amendment to the Amended and Restated Memorandum and Articles of Association (A) in a manner that would affect the substance or timing of the Company’s obligation to redeem 100% of the Public Shares if the Company does not complete a Business Combination within the time frame described below or (B) with respect to any other material provision relating to the rights of holders of Public Shares or pre-initial Business Combination activity, unless the Company provides the Public Shareholders with the opportunity to redeem their Public Shares upon approval of any such amendment. The Company has 24 months (or until July 18, 2025), or such earlier liquidation date as the Company’s board of directors may approve, to consummate an initial Business Combination. If the Company is unable to complete a Business Combination within 24 months, or such earlier liquidation date as the Company’s board of directors may approve, from the closing of the Initial Public Offering (the “Combination Period”), the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten The Sponsor, officers and directors will not be entitled to liquidation rights with respect to the Founder Shares if the Company fails to complete a Business Combination within the Combination Period. However, if the Initial Shareholders should acquire Public Shares in or after the Initial Public Offering, they will be entitled to liquidating distributions from the Trust Account with respect to such Public Shares if the Company fails to complete a Business Combination within the Combination Period. The underwriters have agreed to waive their rights to the deferred underwriting commission (see Note 6) held in the Trust Account in the event the Company does not complete a Business Combination within the Combination Period and, in such event, such amounts will be included with the other funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.10. In order to protect the amounts held in the Trust Account, the Sponsor has agreed to be liable to the Company if and to the extent any claims by a third party (except for the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or by a prospective target business with which the Company has entered into a letter of intent, confidentiality or other similar agreement or business combination agreement, reduce the amount of funds in the Trust Account to below (i) $10.10 per public share or (ii) such lesser amount per public share held in the Trust Account as of the date of the liquidation of the Trust Account due to reductions in the value of the trust assets, in each case net of the interest which may be withdrawn to pay Company taxes. This liability will not apply with respect to any claims by a third party or Target that executed an agreement waiving any and all rights to seek access to the Trust Account (whether or not such agreement is enforceable) or to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act. Liquidity As of June 30, 2023, the Company had no cash, $1,007,333 of deferred offering costs and a working capital deficit of $739,760. On July 18, 2023, the Company consummated the Initial Public Offering of 30,500,000 Units, generating gross proceeds of $305,000,000. Additionally, simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of 9,540,000 Private Placement Warrants at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $9,540,000. Until the consummation of the Initial Public Offering, the Company’s liquidity needs was satisfied through the payment of $25,000 to cover certain offering costs of the Company in exchange for issuance of Class F ordinary shares and loan proceeds from an affiliate of the Sponsor of up to $300,000 under the promissory note. Until the consummation a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. In connection with the Company’s assessment of going concern considerations in accordance with the authoritative guidance in Financial Accounting Standard Board (“FASB”) Accounting Standards Update (“ASU”) 2014-15, “Disclosures of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that the Company currently maintains sufficient liquidity it needs to sustain operations for a reasonable period of time, which is considered to be at least one year from the date that the financial statements are issued.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 17, 2023, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on July 25, 2023. The interim results for the period from April 12, 2023 (inception) through June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods. Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates. Deferred Offering Costs The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A—“Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and Public Warrants (as defined below), using the residual method by allocating Initial Public Offering proceeds first to assigned value of the Public Warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares will be charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Warrants will be charged to shareholder’s equity as Public Warrants and Private Placement Warrants after management’s evaluation will be accounted for under equity treatment. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature. Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented. Net Loss per Ordinary Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares issued and outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,125,000 Class F ordinary shares that are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4). At June 30, 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. Warrant Instruments The Company will account for the Public Warrants and Private Placement Warrants to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging,” whereby under that provision, warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, the Company evaluated and will classify the warrant instrument under equity treatment at its assigned value. There are no Public Warrants or Private Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU 2020-06 as of April 12, 2023 (inception). There was no effect to the Company’s presented financial statements. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

INITIAL PUBLIC OFFERING

INITIAL PUBLIC OFFERING	3 Months Ended
	Jun. 30, 2023
INITIAL PUBLIC OFFERING
INITIAL PUBLIC OFFERING	NOTE 3. INITIAL PUBLIC OFFERING Pursuant to the Initial Public Offering on July 18, 2023, the Company sold 30,500,000 Units, which includes a partial exercise by the underwriters of their over-allotment option in the amount of 500,000 Units, at a purchase price of $10.00 per Unit generating gross proceeds of $305,000,000. Each Unit consists of one Class A ordinary share and one-half

PRIVATE PLACEMENT

PRIVATE PLACEMENT	3 Months Ended
	Jun. 30, 2023
PRIVATE PLACEMENT
PRIVATE PLACEMENT	NOTE 4. PRIVATE PLACEMENT Simultaneously with the closing of the Initial Public Offering, the Private Warrantholders purchased an aggregate of 9,540,000 Private Placement Warrants, at a price of $1.00 per Private Placement Warrant, or $9,540,000 in the aggregate, in a private placement. Each whole Private Placement Warrant is exercisable to purchase one whole Class A ordinary share at a price of $11.50 per share. A portion of the proceeds from the sale of the Private Placement Warrants to the Private Warrantholders were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless. The Private Warrantholders and the Company’s officers and directors will agree, subject to limited exceptions, not to transfer, assign or sell any of their Private Placement Warrants until 30 days after the completion of the initial Business Combination.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	3 Months Ended
	Jun. 30, 2023
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS	NOTE 5. RELATED PARTY TRANSACTIONS Founder Shares On April 13, 2023, the Sponsor paid an aggregate of $25,000 to cover certain offering costs of the Company in exchange for issuance of 5,750,000 Class F ordinary shares, which were issued on April 24, 2023. On June 16, 2023, the Company issued 2,875,000 additional Founder Shares to the Sponsor in connection with a share capitalization, resulting in the Sponsor holding an aggregate of 8,625,000 Founder Shares, for approximately $0.003 per share. The Founder Shares include an aggregate of up to 1,125,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so that the number of Founder Shares will represent 20.0% of the Company’s issued and outstanding shares after the Initial Public Offering. The underwriters purchased 500,000 units subject to the over-allotment option on July 18, 2023 and as a result, only 1,000,000 Class F ordinary shares are subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period. The Initial Shareholders have agreed not to transfer, assign or sell any of the Founder Shares until one year after the date of the consummation of the initial Business Combination or earlier if, subsequent to the initial Business Combination, (i) the reported last sale price of the Company’s Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days after the initial Business Combination or (ii) the date on which the Company consummates a liquidation, merger, share exchange, or other similar transaction which results in all of the Company’s public shareholders having the right to exchange their ordinary shares of for cash, securities or other property. Related Party Loans On April 24, 2023, an affiliate of the Sponsor agreed to loan the Company up to $300,000 pursuant to a promissory note (the “Note”). The Note is non- interest bearing, unsecured and due on the earlier of (i) October 21, 2023 and (ii) the consummation of the Initial Public Offering. The Company intends to repay the Note from the proceeds of the Initial Public Offering not being placed in the Trust Account. As of June 30, 2023, the Company has borrowed $158,006 under the Note and is now due on demand. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor, or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined, and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1.5 million of such Working Capital Loans may be convertible into warrants of the post Business Combination entity at a price of $1.00 per warrant. The warrants would be identical to the Private Placement Warrants. As of June 30, 2023, the Company had no borrowings under the Working Capital Loans. Sponsor Loan The Sponsor (or its affiliates or designees) will enter into an agreement to lend the Company $3,000,000 (and up to an additional $450,000 if the underwriters’ over-allotment option is exercised in full) as of the closing date of the Initial Public Offering at no interest (the “Overfunding Loans”). The Overfunding Loans will be repaid upon the closing of the initial Business Combination or converted into warrants of the post-business combination entity at a price of $1.00 per warrant (or any combination thereof), at the Sponsor’s discretion, which warrants will be identical to the Private Placement Warrants. The Overfunding Loans are being extended in order to ensure that the amount in the Trust Account is $10.10 per public share. If the Company does not complete an initial Business Combination, the Company will not repay the Overfunding Loans from amounts held in the Trust Account, and the Trust Account proceeds will be distributed to the Public Shareholders, subject to the limitations described herein; however, the Company may repay the Overfunding Loans if there are funds available outside the Trust Account to do so. There is no outstanding balance as of June 30, 2023. Administrative Support Agreement The Company entered into an agreement which provides that, commencing on July 14, 2023 through the earlier of the consummation of the initial Business Combination and the Company’s liquidation, the Company will reimburse the Sponsor or an affiliate thereof $15,000 per month for office space, utilities, secretarial and administrative support. In addition, the Sponsor, officers and directors, or any of their respective affiliates will be reimbursed for any out-of-pocket expenses incurred in connection with activities on the Company’s behalf such as identifying potential target businesses and performing due diligence on suitable Business Combinations. Any such payments prior to an initial Business Combination will be made using funds held outside the Trust Account.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	3 Months Ended
	Jun. 30, 2023
COMMITMENTS AND CONTINGENCIES
COMMITMENTS AND CONTINGENCIES	NOTE 6. COMMITMENTS AND CONTINGENCIES Registration and Shareholder Rights The holders of Founder Shares, Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and the Overfunding Loans (and any Class A ordinary shares issuable upon the exercise of the Private Placement Warrants and warrants that may be issued upon conversion of Working Capital Loans and upon conversion of the Founder Shares) are entitled to registration rights pursuant to a registration rights agreement entered into on July 13, 2023. These holders are entitled to make up to three demands, that the Company register such securities for sale under the Securities Act. In addition, these holders have “piggy-back” registration rights with respect to certain underwritten offerings the Company may conduct. The Company will bear the expenses incurred in connection with the filing of any such registration statements. Underwriters Agreement The Company granted the underwriters a 45-day option from the date of the prospectus for the Initial Public Offering to purchase up to 4,500,000 additional Units to cover over-allotments, if any. On July 17, 2023, the underwriters notified the Company of their intention to partially exercise its over-allotment option for an additional 500,000 Units at the closing of the Initial Public Offering, July 18, 2023. The underwriters have 45 days from the date of the prospectus for the Initial Public Offering to purchase the remaining 4,000,000 Units. The underwriters were entitled to an underwriting discount of $0.20 per unit, or $6,100,000 in the aggregate, paid upon the closing of the Initial Public Offering on July 18, 2023. In addition, $0.35 per unit, or $10,675,000 in the aggregate, will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement for the Initial Public Offering. Deferred Legal Fees As of June 30, 2023, the Company has a total of $250,000 of deferred legal fees to be paid to the Company’s legal advisors upon consummation of the Business Combination. Risks and Uncertainties In February 2022, the Russian Federation and Belarus commenced a military action with the country of Ukraine. As a result of this action, various nations, including the United States, have instituted economic sanctions against the Russian Federation and Belarus. Further the impact of this actions and related sanctions on the world economy is not determinable as of the date of these financial statements, and the specific impact on the Company’s financial condition, results of operations, and cash flows is also not determinable as of the date of these financial statements.

SHAREHOLDER'S EQUITY

SHAREHOLDER'S EQUITY	3 Months Ended
	Jun. 30, 2023
SHAREHOLDER'S EQUITY
SHAREHOLDER'S EQUITY	NOTE 7. SHAREHOLDER’S EQUITY Preference Shares Class A Ordinary Shares Class B Ordinary Shares Class F Ordinary Shares Prior to the completion of the initial Business Combination, holders of the Class F ordinary shares will have the right to elect all of the Company’s directors prior to an initial Business Combination. On any other matter submitted to a vote of the Company’s shareholders, holders of the Class A ordinary shareholders, holders of the Class B ordinary shares (if any) and holders of the Class F ordinary shares will vote together as a single class, except as required by law or share exchange rule. Each ordinary share will have one vote on all such matters. Following the completion of the initial Business Combination and the automatic conversion of the Class F ordinary shares into Class B ordinary shares, holders of the Class A ordinary shares and Class B ordinary shares will generally vote together as a single class, except as required by law or stock exchange rule, on all matters presented for a shareholder vote with each Class A ordinary share entitling the holder to one vote per share and each Class B ordinary share entitling the holder to ten votes per share. The Class F ordinary shares will automatically convert into Class B ordinary shares at the time of an initial Business Combination, or earlier at the option of the holder, on a one-for-one basis, and, prior to and following the initial Business Combination, each Class B ordinary share will be convertible, at the option of the holder, into one Class A ordinary share, subject to adjustment for share subdivisions, share dividends, reorganizations, recapitalizations and the like and in each case, subject to further adjustment as provided herein. In the case that additional Class A ordinary shares, or equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to the closing of the initial Business Combination, the ratio at which the Founder Shares shall convert into Class A ordinary shares or Class B ordinary shares, as applicable, will be adjusted (unless the holders of a majority of the outstanding Founder Shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class A ordinary shares or Class B ordinary shares, as applicable, issuable upon conversion thereof will equal, in the aggregate, on an as-converted basis, 20% of the sum of the total number of all ordinary shares outstanding upon the completion of the Initial Public Offering plus all Class A ordinary shares and equity-linked securities issued or deemed issued in connection with the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement warrants issued to the Sponsor or its affiliates upon conversion of Working Capital Loans made to us and the Overfunding Loan). Warrants prospectus current until required to pursuant to the warrant agreement. However, the Company has agreed that as soon as practicable, but in no event later than 20 business days after the closing of the initial Business Combination, the Company will use its commercially reasonable efforts to file with the SEC a post- effective amendment to the registration statement or a new registration statement for the registration, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the Warrants. The Company will use its commercially reasonable efforts to cause the same to become effective within 60 days after the closing of its initial Business Combination and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the Warrants in accordance with the provisions of the warrant agreement. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the board of directors and, in the case of any such issuance to the Sponsor or its affiliates, without taking into account any Founder Shares held by the Sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination (net of redemptions), and (z) the volume weighted average price of the Class A ordinary shares during the 10 trading day period ending on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, (i) the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price and (ii) the $18.00 per share redemption trigger price described under “Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elects, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. The Private Placement Warrants (including the Class A ordinary shares issuable upon exercise of the Private Placement Warrants) will not be transferable, assignable or salable until 30 days after the completion of an initial Business Combination, subject to certain limited exceptions, and they will not be redeemable by the Company. The Private Placement Warrants may be exercised for cash or on a cashless basis. Except as described herein, the Private Placement Warrants have terms and provisions that are identical to those of the Public Warrants, including as to exercise price, exercisability and exercise period. Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00 Once the Public Warrants become exercisable, the Company may redeem the Public Warrants: ● in whole and not in part; ● at a price of $0.01 per Public Warrant; ● upon a minimum of 30 days ’ prior written notice of redemption (the “ 30 day redemption period”); and ● if, and only if, the reported last sale price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30 trading day period commencing on at least 150 days after completion of the initial Business Combination and ending on the third trading day prior to the date the Company sends the notice of redemption to the warrantholders. ​ The Company will not redeem the Public Warrants as described above unless a registration statement under the Securities Act covering the Class A ordinary shares issuable upon exercise of the Public Warrants is effective, and a current prospectus relating to those Class A ordinary shares is available throughout the 30- day redemption period or the company has elected to require exercise of the Public Warrants on a cashless basis. If and when the Public Warrants become redeemable by the Company, the Company may exercise its redemption right even if it is unable to register or qualify the underlying securities for sale under all applicable state securities laws. The Company has established the last of the redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium to the warrant exercise price. If the foregoing conditions are satisfied and the Company issues a notice of redemption of the Public Warrants, each warrantholder will be entitled to exercise its Public Warrant prior to the scheduled redemption date. However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for share subdivisions, share dividends, reorganizations, recapitalizations and the like) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued. In no event will the Company be required to net cash settle any Warrant. If the Company is unable to complete an initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their Warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with respect to such Warrants. Accordingly, the Warrants may expire worthless.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	3 Months Ended
	Jun. 30, 2023
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS	NOTE 8. SUBSEQUENT EVENTS The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the financial statements were issued. Based upon this review, other than as disclosed below and notes above, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On July 13, 2023, the Company, the Sponsor and the Company’s two independent directors entered into securities agreements in which the Sponsor forfeited 100,000 Class F ordinary shares and in turn the Company issued the same number of Class F ordinary shares to the Company’s two independent directors (50,000 Class F ordinary shares to each director). The 100,000 Class F ordinary shares are subject to forfeiture if the independent directors are removed or resigns from the Company’s board of directors before the Company’s initial Business Combination. As disclosed within the notes, on July 18, 2023, the Company consummated the Initial Public Offering of 30,500,000 units, which includes the partial exercise by the underwriters of their over-allotment option in the amount of 500,000 Units, at $10.00 per Unit, generating gross proceeds of $305,000,000. Simultaneously with the closing of the Initial Public Offering, the Company consummated the private sale of 9,540,000 Private Placement Warrants to the Purchasers, at a price of $1.00 per Private Placement Warrant, generating gross proceeds of $9,540,000. Of the net proceeds of the IPO, the sale of the Private Placement Warrants and the Overfunding Loan, $308,050,000, including $10,675,000 of deferred underwriting discounts and commissions, has been deposited into the Trust Account. On July 18, 2023, the direct or indirect owners of the Sponsor loaned the Company an aggregate of $3,050,000, and in exchange, the Company issued unsecured promissory notes to each lender for an aggregate principal amount of $3,050,000.

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	3 Months Ended
	Jun. 30, 2023
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the U.S. the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its Initial Public Offering as filed with the SEC on July 17, 2023, as well as the Company’s Current Report on Form 8-K, as filed with the SEC on July 25, 2023. The interim results for the period from April 12, 2023 (inception) through June 30, 2023 are not necessarily indicative of the results to be expected for the year ending December 31, 2023 or for any future periods.
Emerging Growth Company	Emerging Growth Company The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the JOBS Act, and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates	Use of Estimates The preparation of the financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.
Deferred Offering Costs	Deferred Offering Costs The Company complies with the requirements of the ASC 340-10-S99 and SEC Staff Accounting Bulletin Topic 5A—“Expenses of Offering.” Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC 470-20, “Debt with Conversion and Other Options,” addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Units between Class A ordinary shares and Public Warrants (as defined below), using the residual method by allocating Initial Public Offering proceeds first to assigned value of the Public Warrants and then to the Class A ordinary shares. Offering costs allocated to the Class A ordinary shares will be charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Warrants will be charged to shareholder’s equity as Public Warrants and Private Placement Warrants after management’s evaluation will be accounted for under equity treatment.
Fair Value of Financial Instruments	Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet, primarily due to its short-term nature.
Income Taxes	Income Taxes The Company accounts for income taxes under ASC Topic 740, “Income Taxes,” which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statements and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statements recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2023, there were no unrecognized tax benefits and no amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s tax provision was zero for the period presented.
Net Loss per Ordinary Share	Net Loss per Ordinary Share Net loss per share is computed by dividing net loss by the weighted average number of ordinary shares issued and outstanding during the period, excluding ordinary shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 1,125,000 Class F ordinary shares that are subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters (see Note 4). At June 30, 2023, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
Warrant Instruments	Warrant Instruments The Company will account for the Public Warrants and Private Placement Warrants to be issued in connection with the Initial Public Offering and the private placement in accordance with the guidance contained in FASB ASC Topic 815, “Derivatives and Hedging,” whereby under that provision, warrants that do not meet the criteria for equity treatment must be recorded as liability. Accordingly, the Company evaluated and will classify the warrant instrument under equity treatment at its assigned value. There are no Public Warrants or Private
Recent Accounting Pronouncements	Recent Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, “Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging— Contracts in Entity’s Own Equity (Subtopic 815-40)” (“ASU 2020-06”), to simplify certain financial instruments. ASU 2020-06 eliminates the current models that require separation of beneficial conversion and cash conversion features from convertible instruments and simplifies the derivative scope exception guidance pertaining to equity classification of contracts in an entity’s own equity. The new standard also introduces additional disclosures for convertible debt and freestanding instruments that are indexed to and settled in an entity’s own equity. ASU 2020-06 amends the diluted earnings per share guidance, including the requirement to use the if-converted method for all convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2023 and should be applied on a full or modified retrospective basis. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company adopted ASU 2020-06 as of April 12, 2023 (inception). There was no effect to the Company’s presented financial statements. Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

DESCRIPTION OF ORGANIZATION A_2

DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS (Details) - USD ($)							3 Months Ended
		Jul. 18, 2023	Jul. 13, 2023	Jun. 16, 2023	Apr. 24, 2023	Apr. 13, 2023	Jun. 30, 2023
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount paid	[1]						$ 25,000
Transaction costs							17,966,142
Cash underwriting discount							6,100,000
Deferred underwriting fees							10,675,000
Other offering costs							$ 1,191,142
Threshold minimum aggregate fair market value as a percentage of the assets held in the Trust Account							80%
Threshold percentage of outstanding voting securities of the target to be acquired by post-transaction company to complete business combination							50%
Threshold percentage of public shares subject to redemption without the company's prior written consent							15%
Obligation to redeem public shares if entity does not complete a business combination (as a percent)							100%
Threshold period to consummate initial Business Combination							24 months
Threshold business days for redemption of public shares							10 days
Maximum net interest to pay dissolution expenses							$ 100,000
Cash							0
Deferred offering costs							1,007,333
Working capital deficit							$ 739,760
Purchase price of warrants							$ 11.50
Subsequent Event
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount in Trust Account per public share		$ 10.10
Cash underwriting discount		$ 6,100,000
Deferred underwriting fees		10,675,000
Amount placed in Trust Account		308,050,000
Gross proceeds		305,000,000
Subsequent Event | Overfunding Notes
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Aggregate principal amount		$ 3,050,000
Initial Public Offering | Subsequent Event
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Issue price per share or unit		$ 10
Number of units sold		30,500,000
Gross proceeds from sale of units		$ 305,000,000
Over-allotment option | Subsequent Event
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of units sold		500,000
Private placement | Subsequent Event | Private Placement Warrants
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of units sold		9,540,000
Number of warrants sold		9,540,000
Sale price per warrant		$ 1
Gross proceeds from sale of warrants		$ 9,540,000
Class F ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Par value per share							$ 0.0001
Class F ordinary shares | Subsequent Event
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares issued			50,000
Sponsor | Class F ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares held				8,625,000
Issue price per share or unit				$ 0.003
Sponsor | Class F ordinary shares | Subsequent Event
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of shares issued			100,000
Number of shares held			8,525,000
Founder Shares | Over-allotment option | Subsequent Event
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Number of units sold		500,000
Founder Shares | Sponsor | Class F ordinary shares
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount paid		$ 25,000			$ 25,000	$ 25,000
Number of shares issued				2,875,000	5,750,000	5,750,000
Par value per share					$ 0.0001
Number of shares held				8,625,000
Issue price per share or unit				$ 0.003
Overfunding Loans | Sponsor
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount of loan							$ 3,000,000
Interest rate (in percent)							0%
Conversion price							$ 1
Amount in Trust Account per public share		$ 10.10					$ 10.10
Overfunding Loans | Sponsor | Overfunding Notes
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount of loan							$ 3,050,000
Aggregate principal amount							$ 3,050,000
Overfunding Loans | Sponsor | Subsequent Event
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Amount of loan		$ 3,050,000
Related Party Loans | Sponsor | Notes payable, other payables
DESCRIPTION OF ORGANIZATION AND BUSINESS OPERATIONS
Maximum loan		$ 300,000			$ 300,000
[1] This number includes up to 1,125,000 Class F ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period (see Note 5). The underwriters purchased 500,000 units subject to the over-allotment option on July 18, 2023 and as a result, only 1,000,000 Class F ordinary shares are subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Income Taxes (Details)	Jun. 30, 2023 USD ($)
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Amount of unrecognized tax benefits	$ 0
Amount accrued for interest and penalties	$ 0

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Net Loss per Ordinary Share (Details)	3 Months Ended
	Jun. 30, 2023 shares
Class F ordinary shares | Over-allotment option
Net Loss per Ordinary Share
Number of shares subject to forfeiture	1,125,000

SUMMARY OF SIGNIFICANT ACCOUN_5

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Warrant Instruments (Details)	Jun. 30, 2023 shares
Warrant Instruments
Number of warrants outstanding	0
Public Warrants
Warrant Instruments
Number of warrants outstanding	0
Private Warrants
Warrant Instruments
Number of warrants outstanding	0

INITIAL PUBLIC OFFERING (Detail

INITIAL PUBLIC OFFERING (Details) - USD ($)	Jul. 18, 2023	Jun. 30, 2023
INITIAL PUBLIC OFFERING
Exercise price of warrant		$ 11.50
Subsequent Event
INITIAL PUBLIC OFFERING
Gross proceeds	$ 305,000,000
Initial Public Offering | Subsequent Event
INITIAL PUBLIC OFFERING
Number of units sold	30,500,000
Issue price per share or unit	$ 10
Initial Public Offering | Public Warrants | Subsequent Event
INITIAL PUBLIC OFFERING
Number of warrants in a Unit	0.5
Initial Public Offering | Class A ordinary shares | Subsequent Event
INITIAL PUBLIC OFFERING
Number of shares in a Unit	1
Initial Public Offering | Class A ordinary shares | Public Warrants | Subsequent Event
INITIAL PUBLIC OFFERING
Number of shares to purchase per warrant	1
Exercise price of warrant	$ 11.50
Over-allotment option | Subsequent Event
INITIAL PUBLIC OFFERING
Number of units sold	500,000

PRIVATE PLACEMENT (Details)

PRIVATE PLACEMENT (Details) - USD ($)		3 Months Ended
	Jul. 18, 2023	Jun. 30, 2023
PRIVATE PLACEMENT
Exercise price of warrant		$ 11.50
Class A ordinary shares
PRIVATE PLACEMENT
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination		30 days
Private placement | Private Placement Warrants | Subsequent Event
PRIVATE PLACEMENT
Number of warrants sold	9,540,000
Sale price per warrant	$ 1
Gross proceeds from sale of warrants	$ 9,540,000
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Private placement | Private Placement Warrants | Subsequent Event | Class A ordinary shares
PRIVATE PLACEMENT
Number of shares to purchase per warrant	1
Exercise price of warrant	$ 11.50

RELATED PARTY TRANSACTIONS - Fo

RELATED PARTY TRANSACTIONS - Founder Shares (Details) - USD ($)								3 Months Ended
		Jul. 18, 2023	Jul. 17, 2023	Jul. 13, 2023	Jun. 16, 2023	Apr. 24, 2023	Apr. 13, 2023	Jun. 30, 2023
RELATED PARTY TRANSACTIONS
Amount paid	[1]							$ 25,000
Sponsor | Class F ordinary shares
RELATED PARTY TRANSACTIONS
Number of shares held					8,625,000
Issue price per share					$ 0.003
Percentage of issued and outstanding shares								20%
Over-allotment option | Class F ordinary shares
RELATED PARTY TRANSACTIONS
Maximum number of shares subject to forfeiture								1,125,000
Number of shares subject to forfeiture								1,125,000
Period of over-allotment								45 days
Subsequent Event | Class F ordinary shares
RELATED PARTY TRANSACTIONS
Number of shares issued				50,000
Number of shares subject to forfeiture				100,000
Subsequent Event | Sponsor | Class F ordinary shares
RELATED PARTY TRANSACTIONS
Number of shares issued				100,000
Number of shares held				8,525,000
Maximum number of shares subject to forfeiture				1,125,000
Percentage of issued and outstanding shares				20%
Subsequent Event | Over-allotment option
RELATED PARTY TRANSACTIONS
Number of units sold		500,000
Period of over-allotment		45 days	45 days
Subsequent Event | Over-allotment option | Class F ordinary shares
RELATED PARTY TRANSACTIONS
Maximum number of shares subject to forfeiture		1,000,000
Number of shares subject to forfeiture		1,000,000
Period of over-allotment		45 days
Founder Shares | Sponsor | Class F ordinary shares
RELATED PARTY TRANSACTIONS
Amount paid		$ 25,000				$ 25,000	$ 25,000
Number of shares issued					2,875,000	5,750,000	5,750,000
Number of shares held					8,625,000
Issue price per share					$ 0.003
Maximum number of shares subject to forfeiture					1,125,000
Percentage of issued and outstanding shares					20%
Threshold period for not to transfer, assign or sell any of shares after the completion of the Business Combination								1 year
Stock price trigger to transfer, assign or sell any shares after the completion of the Business Combination (in dollars per share)								$ 12
Threshold trading days for transfer, assign or sale of shares after the completion of the Business Combination								20 days
Threshold consecutive trading days for transfer, assign or sale of shares after the completion of the business combination								30 days
Threshold period after the Business Combination in which the 20 trading days within any 30 trading day period commences								150 days
Founder Shares | Subsequent Event | Over-allotment option
RELATED PARTY TRANSACTIONS
Number of units sold		500,000
[1] This number includes up to 1,125,000 Class F ordinary shares subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period (see Note 5). The underwriters purchased 500,000 units subject to the over-allotment option on July 18, 2023 and as a result, only 1,000,000 Class F ordinary shares are subject to forfeiture if the remainder of the over-allotment option is not exercised in full or in part by the underwriters within the 45 day over-allotment period.

RELATED PARTY TRANSACTIONS - Re

RELATED PARTY TRANSACTIONS - Related Party Loans (Details) - Related Party Loans - USD ($)	3 Months Ended
	Jun. 30, 2023	Jul. 18, 2023	Apr. 24, 2023
Note | Sponsor
RELATED PARTY TRANSACTIONS
Maximum loan		$ 300,000	$ 300,000
Amount borrowed	$ 158,006
Working Capital Loans | Sponsor or an affiliate of the Sponsor, or officers and directors
RELATED PARTY TRANSACTIONS
Maximum amount of loan convertible into warrants			$ 1,500,000
Conversion price per warrant			$ 1
Amount borrowed	$ 0

RELATED PARTY TRANSACTIONS - Sp

RELATED PARTY TRANSACTIONS - Sponsor Loan (Details) - Overfunding Loans - Sponsor - USD ($)		3 Months Ended
	Jul. 18, 2023	Jun. 30, 2023
RELATED PARTY TRANSACTIONS
Amount of loan		$ 3,000,000
Additional amount of loan		$ 450,000
Interest rate (in percent)		0%
Conversion price		$ 1
Amount in Trust Account per public share	$ 10.10	$ 10.10
Outstanding balance		$ 0

RELATED PARTY TRANSACTIONS - Ad

RELATED PARTY TRANSACTIONS - Administrative Support Agreement (Details)	Jul. 14, 2023 USD ($)
Administrative Support Agreement | Subsequent Event | Sponsor or an affiliate
RELATED PARTY TRANSACTIONS
Amount per month for office space, utilities, secretarial and administrative support.	$ 15,000

COMMITMENTS AND CONTINGENCIES -

COMMITMENTS AND CONTINGENCIES - Registration and Shareholder Rights (Details)	3 Months Ended
	Jun. 30, 2023 item
COMMITMENTS AND CONTINGENCIES
Maximum number of demands for registration of securities	3

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES - Underwriters Agreement (Details) - USD ($)			3 Months Ended
	Jul. 18, 2023	Jul. 17, 2023	Jun. 30, 2023
COMMITMENTS AND CONTINGENCIES
Underwriting discount			$ 6,100,000
Deferred underwriting commissions			$ 10,675,000
Subsequent Event
COMMITMENTS AND CONTINGENCIES
Underwriting discount per unit	$ 0.20
Underwriting discount	$ 6,100,000
Deferred underwriting commissions per unit	$ 0.35
Deferred underwriting commissions	$ 10,675,000
Over-allotment option | Subsequent Event
COMMITMENTS AND CONTINGENCIES
Period of over-allotment	45 days	45 days
Maximum number of units to be issued	4,500,000	4,000,000
Number of units sold	500,000

COMMITMENTS AND CONTINGENCIES_3

COMMITMENTS AND CONTINGENCIES - Deferred Legal Fees (Details)	Jun. 30, 2023 USD ($)
COMMITMENTS AND CONTINGENCIES
Deferred legal fees	$ 250,000

SHAREHOLDER'S EQUITY - Preferre

SHAREHOLDER'S EQUITY - Preferred Shares (Details)	Jun. 30, 2023 $ / shares shares
SHAREHOLDER'S EQUITY
Preference shares, shares authorized	5,000,000
Preference shares, par value | $ / shares	$ 0.0001
Preference shares, shares issued	0
Preference shares, shares outstanding	0

SHAREHOLDER'S EQUITY - Ordinary

SHAREHOLDER'S EQUITY - Ordinary Shares (Details)				3 Months Ended
	Jul. 18, 2023 shares	Jul. 17, 2023	Jul. 13, 2023 USD ($) shares	Jun. 30, 2023 Vote $ / shares shares	Jun. 16, 2023 $ / shares shares	Apr. 24, 2023 shares
Subsequent Event | Over-allotment option
SHAREHOLDERS' EQUITY
Number of units sold	500,000
Period of over-allotment	45 days	45 days
Class A ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares, shares authorized				500,000,000
Ordinary shares, par value | $ / shares				$ 0.0001
Ordinary shares, shares issued				0
Ordinary shares, shares outstanding				0
Number of votes per share | Vote				1
Conversion ratio				1
Class B ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares, shares authorized				50,000,000
Ordinary shares, par value | $ / shares				$ 0.0001
Ordinary shares, shares issued				0
Ordinary shares, shares outstanding				0
Number of votes per share | Vote				10
Conversion ratio				1
Class F ordinary shares
SHAREHOLDERS' EQUITY
Ordinary shares, shares authorized				50,000,000
Ordinary shares, par value | $ / shares				$ 0.0001
Ordinary shares, shares issued				8,625,000
Ordinary shares, shares outstanding				8,625,000
Number of votes per share				1
Conversion ratio				1
Class F ordinary shares | Over-allotment option
SHAREHOLDERS' EQUITY
Maximum number of shares subject to forfeiture				1,125,000
Number of shares subject to forfeiture				1,125,000
Period of over-allotment				45 days
Class F ordinary shares | Subsequent Event
SHAREHOLDERS' EQUITY
Number of shares issued			50,000
Number of shares subject to forfeiture			100,000
Class F ordinary shares | Subsequent Event | Over-allotment option
SHAREHOLDERS' EQUITY
Maximum number of shares subject to forfeiture	1,000,000
Number of shares subject to forfeiture	1,000,000
Period of over-allotment	45 days
Class F ordinary shares | Sponsor
SHAREHOLDERS' EQUITY
Number of shares held					8,625,000
Issue price per share | $ / shares					$ 0.003
Percentage of issued and outstanding shares				20%
Ordinary shares, shares issued					2,875,000	5,750,000
Class F ordinary shares | Sponsor | Subsequent Event
SHAREHOLDERS' EQUITY
Number of shares issued			100,000
Number of shares held			8,525,000
Number of shares forfeited			100,000
Maximum number of shares subject to forfeiture			1,125,000
Consideration shares subject to forfeiture | $			$ 0
Percentage of issued and outstanding shares			20%

SHAREHOLDER'S EQUITY - Warrants

SHAREHOLDER'S EQUITY - Warrants (Details)	3 Months Ended
	Jun. 30, 2023 $ / shares shares
Warrant Instruments
Number of warrants outstanding | shares	0
Exercise price of warrant	$ 11.50
Expiration term (in years)	5 years
Warrants exercisable term after the completion of an initial Business Combination	30 days
Threshold period for filling registration statement after business combination	20 days
Threshold period for registration statement to be effective after which warrants can be expired or redeemed	60 days
Redemption of warrants for cash when the price per Class A ordinary share equals or exceeds $18.00
Warrant Instruments
Redemption price per warrant (in dollars per share)	$ 0.01
Minimum threshold written notice period for redemption of warrants	30 days
Threshold trading days for redemption of warrants	20 days
Threshold period for completion of Business Combination	150 days
Class A ordinary shares
Warrant Instruments
Percentage of gross proceeds on total equity proceeds	60%
Threshold trading days for calculating market value	10 days
Adjustment of exercise price of warrants based on market value and newly issued price (as a percent)	115%
Stock price trigger for redemption of public warrants (in dollars per share)	$ 18
Adjustment of redemption price of stock based on market value and newly issued price (as a percent)	180%
Threshold period for not to transfer, assign or sell any of their shares or warrants after the completion of the initial business combination	30 days
Redemption period of warrants	30 days
Class A ordinary shares | Minimum
Warrant Instruments
Threshold issue price for capital raising purposes in connection with the closing of a Business Combination	$ 9.20
Private Placement Warrants
Warrant Instruments
Number of warrants outstanding | shares	0

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details)			3 Months Ended
	Jul. 18, 2023 USD ($) $ / shares shares	Jul. 13, 2023 director shares	Jun. 30, 2023 USD ($) shares	Jun. 16, 2023 $ / shares
Subsequent Event [Line Items]
Deferred underwriting commissions | $			$ 10,675,000
Overfunding Loans | Sponsor
Subsequent Event [Line Items]
Amount of loan | $			3,000,000
Overfunding Notes | Overfunding Loans | Sponsor
Subsequent Event [Line Items]
Amount of loan | $			3,050,000
Aggregate principal amount | $			$ 3,050,000
Class F ordinary shares | Sponsor
Subsequent Event [Line Items]
Issue price per share or unit | $ / shares				$ 0.003
Class F ordinary shares | Over-allotment option
Subsequent Event [Line Items]
Number of shares subject to forfeiture | shares			1,125,000
Subsequent Event
Subsequent Event [Line Items]
Gross proceeds | $	$ 305,000,000
Amount placed in Trust Account | $	308,050,000
Deferred underwriting commissions | $	10,675,000
Subsequent Event | Overfunding Loans | Sponsor
Subsequent Event [Line Items]
Amount of loan | $	3,050,000
Subsequent Event | Overfunding Notes
Subsequent Event [Line Items]
Aggregate principal amount | $	$ 3,050,000
Subsequent Event | Initial Public Offering
Subsequent Event [Line Items]
Number of units sold | shares	30,500,000
Issue price per share or unit | $ / shares	$ 10
Subsequent Event | Over-allotment option
Subsequent Event [Line Items]
Number of units sold | shares	500,000
Subsequent Event | Private placement | Private Placement Warrants
Subsequent Event [Line Items]
Number of units sold | shares	9,540,000
Number of warrants sold | shares	9,540,000
Sale price per warrant | $ / shares	$ 1
Gross proceeds from sale of warrants | $	$ 9,540,000
Subsequent Event | Class F ordinary shares
Subsequent Event [Line Items]
Number of independent directors to whom the shares issued | director		2
Number of shares issued | shares		50,000
Number of shares subject to forfeiture | shares		100,000
Subsequent Event | Class F ordinary shares | Sponsor
Subsequent Event [Line Items]
Number of shares forfeited | shares		100,000
Number of shares issued | shares		100,000
Subsequent Event | Class F ordinary shares | Over-allotment option
Subsequent Event [Line Items]
Number of shares subject to forfeiture | shares	1,000,000

Pay vs Performance Disclosure

Pay vs Performance Disclosure	3 Months Ended
	Jun. 30, 2023 USD ($)
Pay vs Performance Disclosure
Net Income (Loss)	$ (7,427)

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false